CSF3 and disease arising from reactivation of latent virus: From week twenty four to twenty five after HCT, once viral latent infection was established, mice were then treated daily with G-CSF to stimulate HCMV/GLuc reactivation in order to amplify a putative residual viral infection in mice, making the monitoring more sensitive and traceable (Fig 2A).